(MedPage Today) — Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data from the VALOR trial and its open…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






